Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von HC Wainwright 

Precision BioSciences Inc diskutieren

Precision BioSciences Inc

WKN: A2PGA1 / Symbol: DTIL / Name: Precision BioSciences / Aktie / Biotechnologie & medizinische Forschung / ? /

0,35 €
-1,71 %

7 0
7
0
Einschätzung Buy
Rendite (%) -59,36 %
Kursziel 16,09
Veränderung
Endet am 15.03.24

Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.
Ratings data for DTIL provided by MarketBeat

HC Wainwright 
0
Melden Teilen
15.03.23

Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright.
Ratings data for DTIL provided by MarketBeat

HC Wainwright 
0
Melden Teilen
07.08.23 Buy -28,10 %
Einschätzung Buy
Rendite (%) -11,92 %
Kursziel 2,81
Veränderung
Endet am 19.09.24

Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Ratings data for DTIL provided by MarketBeat

HC Wainwright 
0
Melden Teilen
19.09.23
Einschätzung Buy
Rendite (%) -
Kursziel 2,80
Veränderung
Endet am 14.02.25

Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Ratings data for DTIL provided by MarketBeat

HC Wainwright 
0
Melden Teilen
14.02.24
Einschätzung Buy
Rendite (%) -
Kursziel 55,54
Veränderung
Endet am 28.03.25

Precision BioSciences, Inc. (NASDAQ: DTIL) had its price target raised by analysts at HC Wainwright to $60.00. They now have a "buy" rating on the stock.
Ratings data for DTIL provided by MarketBeat

HC Wainwright 
0
Melden Teilen
28.03.24
Einschätzung Buy
Rendite (%) -
Kursziel 17,75
Veränderung
Endet am 30.04.25

Precision BioSciences, Inc. (NASDAQ: DTIL) is now covered by analysts at Guggenheim. They set a "buy" rating and a $19.00 price target on the stock.
Ratings data for DTIL provided by MarketBeat

Guggenheim 
0
Melden Teilen
30.04.24
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

StockNews_com in BGSF Inc. diskutieren
BGSF, Inc. (NYSE: BGSF) is now covered by analysts at St...
12.05.24
StockNews_com in Liqtech International Inc. diskutieren
LiqTech International, Inc. (NASDAQ: LIQT) is now covere...
12.05.24
StockNews_com in Organovo Holdings Inc. diskutieren
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by...
12.05.24
StockNews_com in Goldman Sachs BDC Inc diskutieren
Goldman Sachs BDC, Inc. (NYSE: GSBD) was upgraded by ana...
12.05.24
StockNews_com in BioLase Inc. diskutieren
BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts ...
12.05.24
StockNews_com in ZW Data Action Technologies Inc. diskutieren
ZW Data Action Technologies Inc. (NASDAQ: CNET) is now c...
12.05.24
StockNews_com in Evoke Pharma Inc. diskutieren
Evoke Pharma, Inc. (NASDAQ: EVOK) is now covered by anal...
12.05.24
StockNews_com in Universal Technical Institute diskutieren
Universal Technical Institute, Inc. (NYSE: UTI) was upgr...
11.05.24
Mehr anzeigen